Long Covid Treatment strategies from one of the best clinicians
Discover more from Long Covid Analysed
Long Covid Treatment strategies from one of the best clinicians
Upcoming interview with Dr Shankara Chetty, South Africa
Long Covid treatment approaches from an international expert.
In April 2021, I had the first interaction with Dr Shankara Chetty, a family physician based in semi-rural South Africa.
At that time (April 2012), he had treated over 4000 severe COVID-19 patients with no deaths. Principle of simple observation and focused intervention with high dose steroids and antihistamines.
He is currently at over 14,000 patients treated and has vast clinical experience around COVID-19.
Watch an interview from last year here:
The standout characteristic of his clinical practice, is the instinct to know what to use and when to use it.
Over the past 2 years, I have interviewed him on multiple occasions and seen the evolution in his clinical thinking.
Learning about his approach to long Covid will also be insightful.
If interested, please register on the Eventbrite link below. Limited Availability
Thursday 18th, May 2023 at 19:00PM UK time
Valuable information around treatment and prevention for long Covid.
Long Covid Treatment strategies from one of the best clinicians
Will there be another opportunity to watch this?
Unfortunately I am due to have a baby on 18th May so don’t want to book on and take a space in case I cannot attend ☹️
Time, technology and equipment constraints force many of us miss such great opportunities in knowledge and experience immediately. Sometimes, we partly succeed in catching up much later. Dr. McMillan, you have had extensive amount of discussions with Dr. Shankara Chetty in these two plus years. They are clinical gold mines. They need to be treasured for posterity. Please consider compiling them all into a printed book sometime. For many of us, used to book reading, it will be a boon. On a general note, anti histamines will have to be main line treatment, along with other organ/symptom specific medications. Slowly, but surely they will flush out the residual viral load completely. Their chemistry provides this capability. This could be true for vaccine induced organ issues also. Is there someway of studying the interaction between anti histamines and spike segments generated by m-RNA vaccines, even grossly at the Petri dish level first ?